Get App Open
In App
Credit Cards
Open App
you are here:
Success
Alert
Please select a Day.
Info

Ajanta Pharma Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

73/100
2,593.80
32.50 (1.27%)

As on 10 Sep, 2025 | 03:48

Open Trading A/c
Day Range
2560.10
2604.80
L H
52 Week Range
2327.30
3485.00
L H
Volume
33,869
*
i

* BSE Market Depth (10 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
42 2583.15 2596.95 66
10 2575.00 2600.00 4
26 2574.65 2600.90 1
1 2571.10 2602.35 9
1 2570.00 2604.15 9
0 Total Total 0
Bid / Ask
0.00 / 0.00
73/100
2,594.10
30.35 (1.18%)

As on 10 Sep, 2025 | 04:01

Open Trading A/c
Day Range
2563.00
2609.50
L H
52 Week Range
2022.05
3485.75
L H
Volume
1,195
*
i

* BSE Market Depth (10 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
42 2583.15 2596.95 66
10 2575.00 2600.00 4
26 2574.65 2600.90 1
1 2571.10 2602.35 9
1 2570.00 2604.15 9
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE
MC Essentials
76% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 2,585.30
          Previous Close 2,561.30
          Volume 33,869.00
          Value (Lacs) 878.49
            VWAP 2,588.90
          Beta
          Mkt Cap (Rs. Cr.) 32,400
          High 2,604.80
          Low 2,560.10
          UC Limit 3,073.50
          LC Limit 2,049.10
          52 Week High 3,485.00
          52 Week Low 2,327.30
          Face Value 2.00
          All Time High 3,485.00
          All Time Low 1.82
          20D Avg Volume 116,845
          20D Avg Delivery(%) 56.62
          Book Value Per Share 294.36
          Dividend Yield 1.08
          TTM EPS See historical trend 74.45 (+9.30% YoY)
          TTM PE See historical trend 34.84 (Average PE)
          P/B See historical trend 8.82 (High P/B)
          Sector PE 39.64

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          73/100
          Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 25.57% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 66.26% in Jun 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          10 out of 17 years Ajanta Pharma has given positive returns in September.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          September 43.20% (2013) 9.30% -16.29% (2018) -5.42% 3.24%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Ajanta Pharma

          What's your call on Ajanta Pharma today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          01 May, 2025

          ICICI Securities

          Reco Price 2700.85 Target Price 2500
          30 May, 2025

          Motilal Oswal

          Reco Price 2515.15 Target Price 3260
          30 Jan, 2025

          Motilal Oswal

          Reco Price 2676.05 Target Price 3220
          28 Oct, 2024

          Motilal Oswal

          Reco Price 2921.10 Target Price 3470
          30 Jul, 2024

          Motilal Oswal

          Reco Price 2522.75 Target Price 2935
          03 May, 2024

          Motilal Oswal

          Reco Price 2377.00 Target Price 2565

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Ajanta Pharma 2,593.80 1.27 32,399.70 34.84 8.81 24.28 -21.33 920 4,648 0.00
          Sun Pharma 1,593.40 0.11 382,310.03 36.86 5.53 15.13 -13.23 10,980 52,578 0.03
          Divis Labs 6,031.50 0.48 160,117.37 69.43 11.67 14.63 11.15 2,191 9,360 0.00
          Cipla 1,563.80 0.79 126,316.58 23.42 4.45 16.90 -4.18 5,291 27,547 0.00
          Torrent Pharma 3,591.70 -1.42 121,559.45 60.72 16.20 25.17 4.68 1,911 11,516 0.40

          About the Company

          Ajanta Pharma Limited (APL), is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales. They cater to therapeutic areas like cardiology, ophthalmology and dermatology.They manufacture various dosage forms such as tablets, capsules, injections, ointments and powders. The companys research and development division conduct activities in three aspects namely new drug delivery system (NDDS), formulation and development and herbal/ nutraceutical.
          {"success":1,"data":{"address":{"address1":"\"Ajanta House\", Charkop,","address2":"Kandivli (West),,","city":"Mumbai","state":"Maharashtra","pincode":"400067","telephone1":"022-66061000","telephone2":"","fax1":"022-66061200","fax2":"022-66061300","email":"info@ajantapharma.com","web":"http:\/\/www.ajantapharma.com"},"management":[{"name":"Mannalal B Agrawal","designation":"Chairman"},{"name":"Madhusudan B Agrawal","designation":"Vice Chairman"},{"name":"Yogesh M Agrawal","designation":"Managing Director"},{"name":"Rajesh M Agrawal","designation":"Joint Managing Director"},{"name":"David Rasquinha","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C-13, Pannalal Silk Mill Compound,","address2":"LBS Marg,,","address3":"Bhandup (West),","address4":"","telephone":"022-022-25960320","fax":"022-022-25960329","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400078"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"532331","nseId":"AJANTPHARM","series":"EQ","isinid":"INE031B01049"}}}
          • Registered Office

          • Registrars

          • Management

            • Mannalal B Agrawal

              Chairman

            • Madhusudan B Agrawal

              Vice Chairman

            • Yogesh M Agrawal

              Managing Director

            • Rajesh M Agrawal

              Joint Managing Director

            • David Rasquinha

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              No

          • Details

            • BSE:

              532331

            • NSE:

              AJANTPHARM

            • Series

              EQ

            • ISIN

              INE031B01049